Literature DB >> 9240878

Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IV.

A M Lund1, A C Nicholls, M Schwartz, F Skovby.   

Abstract

Protein-chemical and molecular studies were conducted on all osteogenesis imperfecta (OI) type III/IV patients referred to our hospital during the last 15 y. Of a total of 16 OI type III/IV patients studied, 15 patients were heterozygous for a mutation in one of the two genes coding for collagen I, COL1A1 or COL1A2. Cultured fibroblasts from these 15 patients produced both normal and abnormal collagen I molecules, pointing to a dominant-negative effect of the mutation. Nine mutations had not been described previously. Parental mosaicism was demonstrated in three families. In the 16th child the causative mutation was not found. In conclusion, OI type III/IV in most patients of Western European ancestry is caused by dominant mutations in the genes for collagen I, and recurrence of OI is caused in most cases by parental gonadal mosaicism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240878     DOI: 10.1111/j.1651-2227.1997.tb08573.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

1.  Anthropometry of patients with osteogenesis imperfecta.

Authors:  A M Lund; J Müller; F Skovby
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

Review 2.  Osteogenesis imperfecta: practical treatment guidelines.

Authors:  F Antoniazzi; M Mottes; P Fraschini; P C Brunelli; L Tatò
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

3.  Gonadal mosaicism and familial adenomatous polyposis.

Authors:  Angela L Schwab; Thérèse M F Tuohy; Michelle Condie; Deborah W Neklason; Randall W Burt
Journal:  Fam Cancer       Date:  2007-11-18       Impact factor: 2.375

4.  High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta.

Authors:  Wayne A Cabral; Joan C Marini
Journal:  Am J Hum Genet       Date:  2004-03-11       Impact factor: 11.025

Review 5.  Detectable clonal mosaicism in the human genome.

Authors:  Mitchell J Machiela; Stephen J Chanock
Journal:  Semin Hematol       Date:  2013-10       Impact factor: 3.851

6.  COL4A1 mutations cause ocular dysgenesis, neuronal localization defects, and myopathy in mice and Walker-Warburg syndrome in humans.

Authors:  Cassandre Labelle-Dumais; David J Dilworth; Emily P Harrington; Michelle de Leau; David Lyons; Zhyldyz Kabaeva; M Chiara Manzini; William B Dobyns; Christopher A Walsh; Daniel E Michele; Douglas B Gould
Journal:  PLoS Genet       Date:  2011-05-19       Impact factor: 5.917

Review 7.  A Case Based Approach to Clinical Genetics of Thoracic Aortic Aneurysm/Dissection.

Authors:  Betti Giusti; Stefano Nistri; Elena Sticchi; Rosina De Cario; Rosanna Abbate; Gian Franco Gensini; Guglielmina Pepe
Journal:  Biomed Res Int       Date:  2016-05-25       Impact factor: 3.411

8.  The impact of psycho-educational training on the psychosocial adjustment of caregivers of osteogenesis imperfecta patients.

Authors:  Satı Bozkurt; Leyla Baysan Arabacı; Senay Vara; Samim Ozen; Damla Gökşen; Sükran Darcan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.